Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
about
The Therapeutic Value of Bone Marrow-Derived Endothelial Progenitor Cell Transplantation after Intracerebral Hemorrhage in Rats.In Vivo Anastomosis and Perfusion of a Three-Dimensionally-Printed Construct Containing Microchannel NetworksBiomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction.Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardiumVascular stem/progenitor cells: current status of the problem.Stem cell therapy for the systemic right ventricle.Optimal Environmental Stiffness for Stem Cell Mediated Ischemic Myocardium Repair.Regulating Stem Cell Secretome Using Injectable Hydrogels with In Situ Network Formation.Self-assembling peptide hydrogel enables instant epicardial coating of the heart with mesenchymal stromal cells for the treatment of heart failure.Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models.In situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells.Sustained Release of Endothelial Progenitor Cell-Derived Extracellular Vesicles from Shear-Thinning Hydrogels Improves Angiogenesis and Promotes Function after Myocardial Infarction.Fibrin Glue-aided, Instant Epicardial Placement Enhances the Efficacy of Mesenchymal Stromal Cell-Based Therapy for Heart Failure.
P2860
Q33621833-0BAD709D-B6C9-4B20-B5E3-AEE47AFC5EEFQ35790547-026C9F7E-03F8-43FF-A85E-BA2FD3092A53Q36127860-8F2A2E27-5CA3-4D54-A6FE-04AD8976A5D3Q36260404-855BD859-A639-4BC8-B538-918B1F168332Q38546240-08388C19-A4F5-436B-A28B-FC071821B6B4Q41997705-2CFBE854-9C0B-446D-94DC-260107F3CC7AQ42259996-9A055E51-DF0F-4046-B35B-24DE1F4D0E6AQ42588105-4E3CCAA2-EC92-4843-AE6E-40F4BF925188Q47631245-2FC5F026-5D4C-4C2D-BC8C-874A6C22894FQ50035033-7EFC7247-0101-4270-9567-15AA4138E908Q50452815-3E826383-4921-49BF-A8C4-49A805B87A7CQ52724942-243F1AB5-B801-4605-8399-1B0F6FB36E3BQ55395202-B168C0F4-0C16-414B-A668-8416F1B62CA1
P2860
Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@ast
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@en
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@nl
type
label
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@ast
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@en
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@nl
prefLabel
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@ast
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@en
Tissue-engineered, hydrogel-ba ...... reserves ventricular function.
@nl
P2093
P2860
P921
P1476
Tissue-engineered, hydrogel-ba ...... preserves ventricular function
@en
P2093
Ann C Gaffey
Christopher S Chen
George Hung
Jeffrey E Cohen
John W MacArthur
Kelsey Lloyd
Pavan Atluri
Robert J Emery
Y Joseph Woo
P2860
P304
1090-7; discussion 1097-8
P356
10.1016/J.JTCVS.2014.06.038
P407
P577
2014-06-28T00:00:00Z